The DOI matches its Crossref record; 47 of the 49 references it cites were found in a registry or an index.
Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer
Open accessPublished version of a preprint
Abstract
Pancreatic cancer is projected to become the second leading cause of cancer-related death in the United States by 2020. A familial aggregation of pancreatic cancer has been established, but the cause of this aggregation in most families is unknown. To determine the genetic basis of susceptibility in these families, we sequenced the germline genomes of 638 patients with familial pancreatic cancer and the tumor exomes of 39 familial pancreatic adenocarcinomas. Our analyses support the role of previously identified familial pancreatic cancer susceptibility genes such as BRCA2, CDKN2A, and ATM, and identify novel candidate genes harboring rare, deleterious germline variants for further characterization. We also show how somatic point mutations that occur during hematopoiesis can affect the interpretation of genome-wide studies of hereditary traits. Our observations have important implications for the etiology of pancreatic cancer and for the identification of susceptibility genes in other common cancer types. Significance: The genetic basis of disease susceptibility in the majority of patients with familial pancreatic cancer is unknown. We whole genome sequenced 638 patients with familial pancreatic cancer and demonstrate that the genetic underpinning of inherited pancreatic cancer is highly heterogeneous. This has significant implications for the management of patients with familial pancreatic cancer. Cancer Discov; 6(2); 166–75. ©2015 AACR. This article is highlighted in the In This Issue feature, p. 109
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Deleterious variants in the known pancreatic cancer susceptibility genes account for ~10–20% of the familial clustering of pancreatic cancer.”
In the citing paper
“Pancreatic surveillance is recommended for carriers of germline deleterious variants in cancer susceptibility gene,22–26: BRCA2, ATM, BRCA1, PALB2, CDKN2A, STK11, MLH1 and MSH2.”
In the citing paper
“Our data show, for the first time, that predisposition to MPM is very heterogeneous, similar to that reported for pancreatic cancer and other cancer types [17,18,38].”
From Germline Mutations in DNA Repair Genes Predispose Asbestos-Exposed Patients to Malignant Pleural Mesothelioma (2017) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
Fast and accurate long-read alignment with Burrows-Wheeler transform.
Li, H., & Durbin, R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp698 · Cited by 12,063
<tt>BLAT</tt> —The <tt>BLAST</tt> -Like Alignment Tool
Kent, W. J. (2002) · Genome Research · doi:10.1101/gr.229202 · Cited by 8,480
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
Self-citationAn integrated map of genetic variation from 1,092 human genomes
The 1000 Genomes Project Consortium (2012) · Nature · doi:10.1038/nature11632 · Cited by 7,711
Self-citationMutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
dbSNP: the NCBI database of genetic variation
Sherry, S. T. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.1.308 · Cited by 7,502
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Self-citation
Cited by
Sorted by citations
Items 201–300 of 359
Earl, J., Barreto, E., Castillo, M., Fuentes, R., Rodríguez-Garrote, M., Ferreiro, R., Reguera, P., Muñoz, G., García‐Seisdedos, D., López, J., et al. (2021) · Cancers · doi:10.3390/cancers13071612 · Cited by 10
Hata, T., Mizuma, M., Motoi, F., Ishida, M., Ohtsuka, H., Nakagawa, K., Morikawa, T., Furukawa, T., & Unno, M. (2021) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12482 · Cited by 9
Vay, C., Babaei, S., Safi, S. A., Dizdar, L., Rehders, A., Häberle, L., Roderburg, C., Loosen, S. H., Esposito, I., Knoefel, W. T., et al. (2022) · Cancers · doi:10.3390/cancers14143494 · Cited by 9
Circulating Cell-Free Nucleic Acids as Biomarkers for Diagnosis and Prognosis of Pancreatic Cancer
Marin, A. M., Sanchuki, H. B. S., Namur, G. N., Uno, M., Zanette, D. L., & Aoki, M. N. (2023) · Biomedicines · doi:10.3390/biomedicines11041069 · Cited by 9
Abe, K., Kitago, M., Kosaki, K., Yamada, M., Iwasaki, E., Kawasaki, S., Mizukami, K., Momozawa, Y., Terao, C. C., Yagi, H., et al. (2022) · Cancer Science · doi:10.1111/cas.15316 · Cited by 9
Pancreatic Cancer Surveillance in Carriers of a Germline Pathogenic Variant in CDKN2A
Llach, J., Aguilera, P., Sánchez, A., Ginés, À., Fernández‐Esparrach, G., Soy, G., Sendino, O., Vaquero, E. C., Carballal, S., Ausania, F., et al. (2023) · Cancers · doi:10.3390/cancers15061690 · Cited by 9
Precision medicine meets the DNA damage response in pancreatic cancer
Perkhofer, L., Illing, A., Gout, J., Frappart, P., & Kleger, A. (2018) · Oncoscience · doi:10.18632/oncoscience.392 · Cited by 9
Genomic landscape of pancreatic cancer in the Japanese version of the Cancer Genome Atlas
Imamura, T., Ashida, R., Ohshima, K., Uesaka, K., Sugiura, T., Okamura, Y., Ohgi, K., Ohnami, S., Nagashima, T., & Yamaguchi, K. (2022) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12636 · Cited by 7
Clinical features of germline BRCA1/2 or ATM pathogenic variant positive pancreatic cancer in Japan
Kitamura, H., Morizane, C., Tanabe, N., Ikeda, G., Maruki, Y., Ohba, A., Nagashio, Y., Kondo, S., Hijioka, S., Ueno, H., et al. (2023) · Pancreatology · doi:10.1016/j.pan.2023.10.017 · Cited by 8
Wu, X., Li, Q., Zhang, F., Wang, L., Wang, J., Fan, J., Di, G., & Guo, C. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111892 · Cited by 8
Murali, K., Dwarte, T. M., Nikfarjam, M., Tucker, K., Vaughan, R., Efthymiou, M., Collins, A., Spigelman, A. D., Salmon, L., Johns, A. L., et al. (2021) · Hereditary Cancer in Clinical Practice · doi:10.1186/s13053-021-00190-1 · Cited by 8
Gits, H. C., Tang, A., Harmsen, W. S., Bamlet, W. R., Graham, R. P., Petersen, G. M., Smyrk, T. C., Mahipal, A., Kowalchuk, R. O., Ashman, J. B., et al. (2021) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-21-55 · Cited by 7
Self-citationVoutsadakis, I. A., & Digklia, A. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45030135 · Cited by 8
High Growth Rate of Pancreatic Ductal Adenocarcinoma in CDKN2A-p16-Leiden Mutation Carriers
Ibrahim, I. S., Wasser, M. N. J. M., Wu, Y., Inderson, A., Cappel, W. H. D. V. T. N., Morreau, H., Hes, F. J., Veenendaal, R. A., Putter, H., Feshtali, S., et al. (2018) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-18-0035 · Cited by 8
S3-Leitlinie Exokrines Pankreaskarzinom – Version 3.1
Seufferlein, T. T. W., Mayerle, J. V., Boeck, S. H., Brunner, T. B., Ettrich, T. J., Grenacher, L., Gress, T. M., Hackert, T., Heinemann, V., Kestler, A. M. R., et al. (2024) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2338-3533 · Cited by 7
Hereditäres Magen- und Pankreaskarzinom
Langner, C. (2017) · Der Pathologe · doi:10.1007/s00292-017-0297-6 · Cited by 8
Tezuka, K., Okamura, Y., Sugiura, T., Ito, T., Yamamoto, Y., Ashida, R., Ohgi, K., & Uesaka, K. (2020) · Journal of Gastroenterology · doi:10.1007/s00535-020-01730-7 · Cited by 7
Zimmermann, M. T., Mathison, A., Stodola, T. J., Evans, D. B., Abrudan, J., Demos, W., Tschannen, M., Aldakkak, M., Geurts, J. L., Lomberk, G. A., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.606820 · Cited by 7
Double germline mutations in APC and BRCA2 in an individual with a pancreatic tumor
Goehringer, C., Sutter, C., Kloor, M., Gebert, J. F., Slater, E. P., Keller, M., Treiber, I., Ganschow, P., Kadmon, M., & Moog, U. (2016) · Familial Cancer · doi:10.1007/s10689-016-9952-y · Cited by 7
Ancillary Techniques in Cytologic Specimens Obtained from Solid Lesions of the Pancreas: A Review
Heymann, J. J., & Siddiqui, M. T. (2019) · Acta Cytologica · doi:10.1159/000497153 · Cited by 7
Is the Early Detection of Pancreatic Cancer Possible? It Is Good News, Bad News
Hruban, R. H. (2019) · Pancreas · doi:10.1097/mpa.0000000000001299 · Cited by 7
Self-citationSchwartz, M., Korenbaum, C., Meriem, B., Mary, M., Colas, C., Coulet, F., Mélissa, P., Jonveaux, P., Ingster, O., Granier, S., et al. (2019) · Clinical Genetics · doi:10.1111/cge.13629 · Cited by 7
Laberko, A. L., Balashov, D., Deripapa, E. V., Soldatkina, O., Raikina, E. V., Maschan, A., Novichkova, G. A., & Shcherbina, A. Y. (2019) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-019-1073-x · Cited by 7
Screening for Pancreatic Cancer—Is There Hope?
Lennon, A. M., Hruban, R. H., & Klein, A. P. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.3323 · Cited by 7
Self-citationExamination of ATM, BRCA1, and BRCA2 promoter methylation in patients with pancreatic cancer
Zhou, C., Porter, N. R., Borges, M. W., Gauthier, C. D., Ferguson, L. G., Huang, B., Nanda, N., He, J. P., Laheru, D. A., Hruban, R. H., et al. (2021) · Pancreatology · doi:10.1016/j.pan.2021.03.015 · Cited by 5
Self-citationPeters, N. V., & Kunstman, J. W. (2021) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2021.67 · Cited by 6
Shoucair, S., Baker, A. R., & Yu, J. (2021) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12514 · Cited by 5
Blackford, A. L., Childs, E. J., Porter, N. R., Petersen, G. M., Rabe, K. G., Gallinger, S., Borgida, A., Syngal, S., Coté, M. L., Schwartz, A. G., et al. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01580-x · Cited by 6
Self-citationMuhammad, N., Sadaqat, R., Naeemi, H., Masood, I., Hassan, U., Ijaz, B., Hanif, F., Syed, A. A., Yusuf, M. A., & Rashid, M. U. (2022) · HPB · doi:10.1016/j.hpb.2022.09.003 · Cited by 6
Astiazarán-Symonds, E., Graham, C., Kim, J., Tucker, M. A., Ingvar, C., Helgadóttir, H., Pastorino, L., van Doorn, R., Sampson, J. N., Zhu, B., et al. (2022) · JCO Precision Oncology · doi:10.1200/po.22.00145 · Cited by 6
A new vulnerability to BET inhibition due to enhanced autophagy in BRCA2 deficient pancreatic cancer
Lee, E., Archasappawat, S., Ji, K. Y., Pena, J., Fernández-Vega, V., Gangaraju, R., Beesabathuni, N. S., Kim, M. J., Tian, Q., Shah, P. S., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06145-9 · Cited by 7
Rapposelli, I. G., Zampiga, V., Cangini, I., Arcangeli, V., Ravegnani, M., Valgiusti, M., Pini, S., Tamberi, S., Bartolini, G., Passardi, A., et al. (2021) · BMC Cancer · doi:10.1186/s12885-021-08368-5 · Cited by 7
Roberts, N. J., & Klein, A. P. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7193-0_78 · Cited by 6
Self-citationFamilial pancreatic cancer with PALB2 and NBN pathogenic variants: a case report
Abe, K., Ueki, A., Urakawa, Y., Kitago, M., Yoshihama, T., Nanki, Y., Kitagawa, Y., Aoki, D., Kosaki, K., & Hirasawa, A. (2021) · Hereditary Cancer in Clinical Practice · doi:10.1186/s13053-020-00160-z · Cited by 6
Xu, Y., Nipper, M. H., Dominguez, A. A., He, C., Sharkey, F. E., Khan, S., Xu, H., Zhou, D., Zheng, L., Luan, Y., et al. (2026) · Journal of Clinical Investigation · doi:10.1172/jci194395 · Cited by 5
Fulton, A., Lamarca, Á., Nuttall, C., McCallum, L., Pihlak, R., O'Reilly, D. A., Lalloo, F. I., McNamara, M. G., Hubner, R. A., Clancy, T., et al. (2019) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v11.i2.102 · Cited by 5
Genomic alterations in tumor tissue and ctDNA from Chinese pancreatic cancer patients.
Xiong, A., Ma, N., Wei, G., Li, C., Li, K., & Wang, B. (2021) · PubMed Central · Cited by 5
Guan, Z., Shen, R., & Begg, C. B. (2021) · Human Heredity · doi:10.1159/000519355 · Cited by 5
Tavano, F., Gioffreda, D., Fontana, A., Palmieri, O., Gentile, A., Latiano, T. P., Latiano, A., Latiano, T. P., Scaramuzzi, M., Maiello, E., et al. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00600-1 · Cited by 5
Early Detection of Pancreatic Cancer
Schwingel, J., Decker, M., Schneider, L., Stürmer, C. J., & Lutz, M. P. (2023) · Oncology Research and Treatment · doi:10.1159/000530790 · Cited by 5
Heinrich, K., Fischer, L. E., Toni, E. N. D., Markwardt, D., Roessler, D., Beyer, G., Günther, M., Ormanns, S., Klauschen, F., Kunz, W. G., et al. (2023) · JCO Precision Oncology · doi:10.1200/po.22.00650 · Cited by 5
Ralli, S., Jones, S. J., Leach, S. R., Lynch, H. T., & Brooks-Wilson, A. R. (2023) · PLoS ONE · doi:10.1371/journal.pone.0287602 · Cited by 4
Soukupová, J., Šťastná, B., Kanwal, M., Hojny, J., Zemánková, P., Borecká, M., Cerna, L., Černá, M., Černá, M., Curtisová, V., et al. (2024) · Cancer Medicine · doi:10.1002/cam4.70103 · Cited by 5
Pathogenic germline variants in Chinese pancreatic adenocarcinoma patients
Yin, X., Shen, H., Wang, H., Wang, Q., Zhang, S., Zhang, C., Jia, Q., Guo, S., Xu, X., Zhang, W., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57520-3 · Cited by 5
Molecular Profiling in Pancreatic Cancer: Current Role and Its Impact on Primary Surgery
Reyes, C. M., Doğruöz, A., Istvánffy, R., Frieß, H., Ceyhan, G. O., & Demir, İ. E. (2021) · Visceral Medicine · doi:10.1159/000519755 · Cited by 5
Ha, C. S. R., Müller‐Nurasyid, M., Petrera, A., Hauck, S. M., Marini, F., Bartsch, D. K., Slater, E. P., & Strauch, K. (2023) · PLoS ONE · doi:10.1371/journal.pone.0280399 · Cited by 5
Rare germline variants in pancreatic cancer and multiple primary cancers: an autopsy study
Fujitani, H., Eguchi, H., Kochi, Y., Arai, T., Muramatsu, M., & Okazaki, Y. (2023) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000787 · Cited by 5
Familial Pancreatic Cancer Research: Bridging Gaps in Basic Research and Clinical Application
Archasappawat, S., Al-Musawi, F., Liu, P., Lee, E., & Hwang, C. (2024) · Biomolecules · doi:10.3390/biom14111381 · Cited by 4
DNA Damage and Repair in Pancreatic Cancer—The Latest Findings
Kozłowska, M., Mik, M., Nowicki, M. O., & Śliwińska, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262010106 · Cited by 5
Jiang, X., O'Neill, A., Smith, K. R., Lai, Z., Carss, K., Wang, Q., & Petrovski, S. (2022) · Genes Chromosomes and Cancer · doi:10.1002/gcc.23042 · Cited by 4
Precursor lesions in familial and hereditary pancreatic cancer
Pflüger, M. J., Brosens, L. A. A., & Hruban, R. H. (2024) · Familial Cancer · doi:10.1007/s10689-024-00359-2 · Cited by 4
Self-citationUnderstanding familial risk of pancreatic ductal adenocarcinoma
Paranal, R. M., Wood, L. D., Klein, A. P., & Roberts, N. J. (2024) · Familial Cancer · doi:10.1007/s10689-024-00383-2 · Cited by 4
Self-citationEarl, J., Fuentes, R., Sanchez, M. E. C., de Paredes, A. G. G., Muñoz, M., Sanjuánbenito, A., Lobo, E., Caminoa, A., Rodríguez, M., Barreto, E., et al. (2024) · Familial Cancer · doi:10.1007/s10689-024-00388-x · Cited by 4
Limijadi, E. K. S., Muniroh, M., Prajoko, Y. W., Tjandra, K. C., & Respati, D. R. P. (2024) · PLoS ONE · doi:10.1371/journal.pone.0299276 · Cited by 5
From Screening to Treatment of Pancreatic Cancer: A Comprehensive Review.
Saif, M. W. (2021) · PubMed · Cited by 4
Cohort profile and heritability assessment of familial pancreatic cancer: a nation-wide study
Tan, M., Brusgaard, K., Gerdes, A., Mortensen, M. B., Detlefsen, S., de Muckadell, O. B. S., & Jøergensen, M. T. (2021) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2021.1937697 · Cited by 4
RAD51B Harbors Germline Mutations Associated With Pancreatic Ductal Adenocarcinoma
Xie, F., Ding, D., Lin, C., Cunningham, D., Wright, M. J., Javed, A. A., Azad, N. A., Lee, V., Donehower, R. C., Jesus‐Acosta, A. D., et al. (2022) · JCO Precision Oncology · doi:10.1200/po.21.00404 · Cited by 4
Self-citationSomatic loss of ATM is a late event in pancreatic tumorigenesis
Paranal, R. M., Jiang, Z., Hutchings, D., Kryklyva, V., Gauthier, C., Fujikura, K., Nanda, N., Huang, B., Skaro, M. F., Wolfgang, C. L., et al. (2023) · The Journal of Pathology · doi:10.1002/path.6136 · Cited by 6
Self-citationDissecting the molecular landscape of pancreatic cancer: towards a precision medicine approach
Pea, A., Liang Cheng, C., & Luchini, C. (2019) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2019.1604135 · Cited by 4
Pancreatic Ductal Organoids React Kras Dependent to the Removal of Tumor Suppressive Roadblocks
Perkhofer, L., Engler, M., Gout, J., Arnold, F., Morawe, M., Breunig, M., Seufferlein, T. T. W., Kleger, A., & Frappart, P. (2019) · Stem Cells International · doi:10.1155/2019/2079742 · Cited by 4
Clinical Utility of Epigenetic Changes in Pancreatic Adenocarcinoma
Thompson, J. K., & Bednar, F. (2021) · Epigenomes · doi:10.3390/epigenomes5040020 · Cited by 4
Roberts, N. J., & Klein, A. P. (2016) · Springer eBooks · doi:10.1007/978-1-4939-6631-8_78-1 · Cited by 4
Self-citationAntwi, S. O., Rabe, K. G., Carlson, E. E., Sicotte, H., Bamlet, W. R., Mills, K. C., Konikoff, T. D., Cerhan, J. R., Couch, F. J., Larson, N. B., et al. (2026) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2026.03.043 · Cited by 3
Self-citationNext‐Generation Sequencing: An Advanced Diagnostic Tool for Detection of Pancreatic Disease/Disorder
Biswas, S., Afrose, S., Mita, M. A., Hasan, M. R., Shimu, M. S. S., Zaman, S., & Saleh, M. A. (2024) · JGH Open · doi:10.1002/jgh3.70061 · Cited by 3
Recent advances in molecular diagnostics and therapeutic targets for pancreatic cancer
Clay, R., & Siddiqi, S. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-819457-7.00016-5 · Cited by 3
Association of germline ATM mutations and survival in pancreatic cancer
Gower, A., Gresham, G. K., Spector, K., Haladjian, N., Lee, J., Mehta, S., Osipov, A., & Hendifar, A. E. (2021) · Annals of Pancreatic Cancer · doi:10.21037/apc-20-38 · Cited by 5
Yu, Y., Chang, K., Chen, J., Bohlender, R. J., Fowler, J., Zhang, D., Huang, M., Chang, P., Li, Y., Wong, J., et al. (2021) · Human Genetics and Genomics Advances · doi:10.1016/j.xhgg.2021.100078 · Cited by 3
Endoplasmic stress-inducing variants in carboxyl ester lipase and pancreatic cancer risk
Kawamoto, M., Yoshida, T., Tamura, K., Dbouk, M. H., Canto, M. I., Burkhart, R. A., He, J. P., Roberts, N. J., Klein, A. P., & Goggins, M. (2022) · Pancreatology · doi:10.1016/j.pan.2022.08.004 · Cited by 3
Self-citationBaz, M., Gondran-Teiller, V., Paillerets, B. B., Cabaret, O., Fievet, A., Dimaria, M., Goldbarg, V., Colas, C., Bonnet-Dupeyron, M. N., Tinat, J., et al. (2022) · Digestive Diseases and Sciences · doi:10.1007/s10620-022-07733-z · Cited by 3
Muhammad, N., Azeem, A., Arif, S., Naeemi, H., Masood, I., Hassan, U., Ijaz, B., Hanif, F., Syed, A. A., Yusuf, M. A., et al. (2023) · Hereditary Cancer in Clinical Practice · doi:10.1186/s13053-023-00269-x · Cited by 3
Upper Gastrointestinal Cancers and the Role of Genetic Testing
Harrold, E. C., & Stadler, Z. K. (2024) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2024.01.006 · Cited by 3
Pancreatic Cancer Screening among High-risk Individuals
Turner, K. M., & Patel, S. H. (2024) · Surgical Clinics of North America · doi:10.1016/j.suc.2024.03.002 · Cited by 3
Characteristics of Pure Familial Pancreatic Cancer Families and Those with Additional Breast Cancer
Bartsch, D. K. (2020) · Open Access Journal of Oncology and Medicine · doi:10.32474/oajom.2020.04.000178 · Cited by 3
Familial pancreatic cancer: who should be considered for genetic testing?
Kartal, K., Guan, Z., Tang, R., Griffin, M., Wang, Y., Braun, D., Klein, A. P., & Hughes, K. S. (2021) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-021-02572-9 · Cited by 3
Self-citationProgress report: familial pancreatic cancer
Mintziras, I., & Bartsch, D. K. (2019) · Familial Cancer · doi:10.1007/s10689-019-00125-9 · Cited by 3
Roberts, N. J., Grant, R. C., Gallinger, S., Klein, A. P., & the Familial Pancreatic Cancer Genome Sequencing Project (2021) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22947 · Cited by 3
Self-citationEditorial: Circulating Biomarkers to Identify Patients With Resectable Pancreatic Cancer
Goggins, M. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx004 · Cited by 3
Self-citationNeoplasms of the Exocrine Pancreas
Wolff, R. A., Li, D., Maitra, A., Tsai, S., Koay, E. J., & Evans, D. B. (2022) · Wiley eBooks · doi:10.1002/9781119000822.hfcm094.pub2 · Cited by 3
Ma, H., Qammar, S., Wang, J.-M., Zhai, A., Li, F., & Hu, H. (2026) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.70281 · Cited by 2
Diagnosis of pancreatic cancer
Sattar, Z., Ali, S., Hussain, I., Sattar, F., Hussain, S., & Ahmad, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-819457-7.00002-5 · Cited by 2
Self-citationZhou, H., He, X., Zhao, J., Mei, Z., Zhang, X., Yuan, W., & Dong, H. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1301652 · Cited by 2
Ataxia Telengectesia Protein Influences Bleomycin-Induced DNA Damage in Human Fibroblast Cells
Gnanasekaran, T. S., & Venkatachalam, P. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01275-z · Cited by 2
Familial and hereditary pancreatic cancer in Japan
Matsubayashi, H., & Morizane, C. (2024) · Familial Cancer · doi:10.1007/s10689-024-00395-y · Cited by 2
Ni, Z., Kundu, P., McKean, D. F., Wheeler, W., Albanes, D., Andreotti, G., Antwi, S. O., Arslan, A. A., Bamlet, W. R., Freeman, L. E. B., et al. (2024) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-24-0096 · Cited by 2
Self-citationGastrointestinal Malignancy: Genetic Implications to Clinical Applications
Trembath, H. E., Yeh, J. J., & Lopez, N. (2024) · Cancer treatment and research · doi:10.1007/978-3-031-61238-1_15 · Cited by 3
Han, F., Zhou, X., Liu, L., Yang, B., Liu, P., Xu, E., Tang, Z., & Zhang, H. (2024) · Oncogene · doi:10.1038/s41388-024-03179-x · Cited by 3
Vornhülz, M., Angelberger, M., Sirtl, S., Philipp, A. B., Rössler, D. C., Ondrejkova, K., Markwardt, D., Heinrich, K., Westphalen, C. B., Heinemann, V., et al. (2025) · Oncology Research and Treatment · doi:10.1159/000545975 · Cited by 2
Oxidative Stress and Gastrointestinal System Cancers
Atay, A. E., Esen, B., & Gökmen, E. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805377-5.00003-5 · Cited by 2
Emerging Therapeutic Targets in Pancreatic Adenocarcinoma
Choe, J. H., & Abbruzzese, J. L. (2016) · Springer eBooks · doi:10.1007/978-1-4939-6631-8_92-1 · Cited by 2
Pancreatic Ductal Adenocarcinoma
Erickson, L. A. (2017) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.07.002 · Cited by 2
Precision Medicine Based on Next-Generation Sequencing and Master Controllers
Dukleska, K., Yeo, C. J., Pishvaian, M. J., & Brody, J. R. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7193-0_71 · Cited by 2
Emerging Therapeutic Targets in Pancreatic Adenocarcinoma
Choe, J. H., & Abbruzzese, J. L. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7193-0_92 · Cited by 2
Pancreatic Cancer Screening: A Narrative Review
Meziani, J., Fuhler, G. M., Bruno, M. J., Cahen, D. L., & Overbeek, K. A. (2024) · Techniques and Innovations in Gastrointestinal Endoscopy · doi:10.1016/j.tige.2024.08.001 · Cited by 2
Klein, A. P. (2018) · doi:10.1002/9781119188421.ch91 · Cited by 2
Self-citationSurveillance Outcome and Genetic Findings in Individuals at High Risk of Pancreatic Cancer
Rosner, G., Scapa, E. F., Ziv, T., Gluck, N., & Ben‐Yehoyada, M. (2023) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000668 · Cited by 2
Diagnostic and Prognostic Markers for Pancreatitis and Pancreatic Ductal Adenocarcinoma
Kantheti, H. S., Hale, M. A., Choudhuri, S. P., Huang, H., Wang, X., Zolghadri, Y., Innamorati, G., Manikonda, S. P. R., Reddy, N. R., Reddy, S., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126619 · Cited by 1
Ex-Vivo 3D Cellular Models of Pancreatic Ductal Adenocarcinoma
Aćimović, I., Gabrielová, V., Martínková, S., Eid, M., Vlažný, J., Moravčík, P., Hlavsa, J., Moráň, L., Cakmakci, R. C., Staňo, P., et al. (2024) · Pancreas · doi:10.1097/mpa.0000000000002393 · Cited by 1
Histopathological and genetic landscape of pancreatic ductal adenocarcinoma and its variants
Caldwell, N. J., & Zhang, M. L. (2025) · Seminars in Diagnostic Pathology · doi:10.1016/j.semdp.2025.150948 · Cited by 1
Cancer risks for ATM variant heterozygotes
Jiao, Y., Goldgar, D. E., Gal, D. L., Cavaciuti, E., Beauvallet, J., Dondon, M., Eon, S., Gall, J. L., d’Enghien, C. D., Delhomelle, H., et al. (2026) · Genetics in Medicine · doi:10.1016/j.gim.2026.102591 · Cited by 1
Clinical Genetic Testing in Gastroenterology
Goodman, R. P., & Chung, D. C. (2016) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2016.23 · Cited by 1
Metadata
- Authors
- Roberts, N. J., Norris, A. L., Petersen, G. M., Bondy, M. L., Brand, R., Gallinger, S., Kurtz, R. C., Olson, S. H., Rustgi, A. K., Schwartz, A. G., Stoffel, E., Syngal, S., Zogopoulos, G., Ali, S. Z., Axilbund, J., Chaffee, K. G., Chen, Y.-C., Cote, M. L., Childs, E. J., Douville, C., Goes, F. S., Herman, J. M., Iacobuzio-Donahue, C., Kramer, M., Makohon-Moore, A., McCombie, R. W., McMahon, K. W., Niknafs, N., Parla, J., Pirooznia, M., Potash, J. B., Rhim, A. D., Smith, A. L., Wang, Y., Wolfgang, C. L., Wood, L. D., Zandi, P. P., Goggins, M., Karchin, R., Eshleman, J. R., Papadopoulos, N., Kinzler, K. W., Vogelstein, B., Hruban, R. H., & Klein, A. P.
- Affiliations
- Howard Hughes Medical Institute (US)
- Johns Hopkins University (US)
- Mayo Clinic (US)
- Baylor College of Medicine (US)
- University of Pittsburgh (US)
- 6Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
- Memorial Sloan Kettering Cancer Center (US)
- Abramson Cancer Center (US)
- Wayne State University (US)
- University of Michigan (US)
- Brigham and Women's Hospital (US)
- Research Institute of the McGill University Health Centre (CA)
- 3Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
- 15Department of Biomedical Engineering, Institute for Computational Medicine, Johns Hopkins University, Baltimore, Maryland.
- 10Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan.
- 19Memorial Sloan Kettering Cancer Center, New York, New York.
- Cold Spring Harbor Laboratory (US)
- 20Stanley Institute for Cognitive Genomics, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
- University of Iowa (US)
- Corresponding author
- Roberts, Nicholas J.
- Kinzler, Kenneth W.
- Vogelstein, Bert
- Hruban, Ralph H.
- Klein, Alison P.
- ORCID
- Roberts, Nicholas J.
- Norris, Alexis L.
- Petersen, Gloria M.
- Bondy, Melissa L.
- Brand, Randall
- Kurtz, Robert C.
- Olson, Sara H.
- Rustgi, Anil K.
- Schwartz, Ann G.
- Stoffel, Elena
- Syngal, Sapna
- Zogopoulos, George
- Ali, Syed Z.
- Douville, Christopher
- Goes, Fernando S.
- Herman, Joseph M.
- Kramer, Melissa
- Makohon-Moore, Alvin
- Niknafs, Noushin
- Pirooznia, Mehdi
- Potash, James B.
- Rhim, Andrew D.
- Smith, Alyssa L.
- Wang, Yuxuan
- Wolfgang, Christopher L.
- Wood, Laura D.
- Zandi, Peter P.
- Goggins, Michael
- Karchin, Rachel
- Eshleman, James R.
- Papadopoulos, Nickolas
- Kinzler, Kenneth W.
- Vogelstein, Bert
- Hruban, Ralph H.
- Klein, Alison P.
- Venue
- Cancer Discovery
- Published
- 2016-02-01
- Volume
- 6
- Issue
- 2
- Pages
- 166-175
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- PMC
- PMC4744563
- OpenAlex
- W2232697670
- Cited by
- 361
- References
- 49
- Citations by year
- 2026: 13 · 2025: 16 · 2024: 42 · 2023: 33 · 2022: 30 · 2021: 58 · 2020: 41 · 2019: 43 · 2018: 35 · 2017: 32 · 2016: 18
- FWCI
- 12.37
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cancer Discovery (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (UL1TR000371, 5p30ca045508-35)
- National Institute of Mental Health (R01MH087979, K01MH093809)
- National Cancer Institute (K99CA190889, R01CA-97075, R01-CA57345, R01CA154823, R00CA190889, R37CA043460, P50CA102701, R01CA057345, P30-CA045508, R01CA097075, R01CA177857, P50CA062924, R37CA057345, P30CA008748, P30CA015083, P30CA006973)
- National Institute of General Medical Sciences (T32GM007309, T32GM007057, T32GM008752)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK060694)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Keywords
- familial pancreatic cancer, pancreatic ductal adenocarcinoma, germline mutations, cancer susceptibility genes, BRCA2, CDKN2A, ATM, somatic mutations, hematopoietic cells, genetic heterogeneity, hereditary cancer predisposition, rare deleterious variants
- MeSH terms
- Carcinoma, Humans, Pancreatic Neoplasms, Point Mutation, Sequence Analysis, DNA, Germ-Line Mutation, Cyclin-Dependent Kinase Inhibitor p16, Genetic Predisposition to Disease, BRCA2 Protein, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
